Wednesday, March 21, 2012

Nutrition should be made a part of medical treatment

 India’s biggest Nutraceuticals, Functional Foods, Dietary Supplements and Ingredients Show - Nutra India Summit 2012 on Day 1 featured a CEO summit and the topic for the panel discussion was “Increasing India’s share of global Neutraceuticals and Nutritional Market.” The panel was chaired by Dr. V. Prakash, FRSC - Distinguished Scientist of CSIR-INDIA; President - Nutrition Society of India; Chairman, Nutra India Summit and the other speakers were Dr. Manfred Eggersdorfer - Senior Vice President, DSM Nutritional Products & Head for Nutritional Science Advocacy, Switzerland, Mr. Sanjaya J. Mariwala - Promoter Director, OmniActive Health Technologies Ltd., Managing Director, Kancor Ingredients Ltd., Dr. Vilas P. Sinkar - Vice President, Research & Development & Head of Unilever R&D, Hindustan Unilever Limited, Mr. Rehan Khan - Country Head & General Manager - India, Abbott Nutrition International, Mr. V.S. Reddy - Managing Director, British Biologicals, Mr. Kumar C. Vasist - Group Manager, Product Development, Abbott Nutrition R&D, Abbott Laboratories, and Dr. Lekh R. Juneja - Representative Director & Executive Vice President, Taiyo Kagaku Co., Ltd., Japan.

Dr. V Prakash chaired the panel and presented the welcome note. The session was opened for discussion with a quote by Dr. Prakash “If pharmaceuticals define efficiency, then Neutraceuticals defines efficacy.” The panel members presented their views on some of the important factors affecting the success of Neutraceuticals in India, which included- Linking farmers, growers to micro, macro and global industries in the market is very crucial in India. Food security and fortification should be the nutritional agenda. Role of nutrition, Neutraceuticals and neutrigenomics should be well understood. New innovations should be encouraged. Customer Delight should be kept in mind. Power of biotechnology and neutrigenomics should be well exploited.
Before inviting the speakers to give their views, he stated that food safety is a crucial issue in Neutraceuticals and India is almost step 8 in FSSAI in the coder language. Laying emphasis on Neutraceuticals he said, “culture, science, Neutraceuticals and nutritionals and humans coexist and have role in improving quality of life of people by global networking of food science and technology with benefit to growers and processors and mega industries in tune with SME’s with a firm but ground to reality regulatory consensus and ethics for a healthy society from pediatrics to geriatrics.”
Dr. Manfred Eggersdorfer, Shared his ideas to overcome the problems of malnutrition and deficiency of micro-nutrients among the people. He suggested that a panel of industry leaders with full expertise in this field should be created and Government should install some programs to generate awareness among the masses and to promote more and more R&D. We have to use naturally available ingredients for the generation of useful and healthy products. Safety assessments and efficacy assessments are a big concern and have to be dealt with.
Mr. Sanjaya J. Mariwala, said the success of neutraceutics will depend on what we dream and how we act to achieve the same. He insisted that the Govt. should frame an agenda to promote the growth of neutraceutics. Talking about R&D he said their work in this field should be encouraged and public and private partnership should be focused more.
He suggested that the industries should focus on the products that are costumer and need focused, more and more educational awareness should be created regarding the action and the mechanism of working of functional foods.
Dr. Vilas P. Sinkar emphasizes the use of right regulations to promote Neutraceuticals. He listed out the features of Indian Neutraceuticals market and said although being a small market (Rupees 4500 crores) which is less than 1% of the world market, it is growing at a rate of 18% which is double than the rate of the rest of the world which is approx.7%.
He further highlighted accessibility, affordability and awareness as the only solutions to the problems faced by Neutraceuticals. Throwing a light on the statistical analysis and the improvement in the field, he said the percentage of physicians in India referring nutritional supplements has gone up to 26% per year since last 4 years, which is a breakthrough. Due to such achievements the Neutraceuticals market in India will be about 100 to 200 billion US Dollar in 2050.
Mr. V.S. Reddy, said their company being the first one to export the Neutraceuticals from India is trying their level best to make Neutraceuticals a success at the highest level. He insisted on the Introduction of nutrition as a part of the medical treatment and generation of more food and technology should be highly encouraged. He enlisted that following all these actions, Neutraceuticals can achieve a growth percentage of 40-50% every year.
Mr. Kumar C. Vasist said that developing credibility for nutrition and education should be at the forefront; the use of traditional medicine should be enhanced. The issues like quality and consistency of the products were his major areas of concern. Listing out the flaws in the infrastructure and the places of manufacture, he pointed out that they need of developing them. Import and export of raw materials and products is a big issue and should be sorted out.
Dr. Lekh R. Juneja said the emphasis should be laid on the ways that can take India on global map and which can pave a pathway for overcoming the micronutrient deficiency. He put forth taste and perception as the major issues to be kept in mind while working with nutritionals and functional foods. He forbid Indian people from following “me too” strategy i.e., rather than copying old products we should focus on the production of new and unique ones. He concluded with the message that We have to make good use of science and technology for designing unique products.
For more information on Nutra India Summit, visit: www.nutraindiasummit.in
Sourced From:Equator Communications